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ABSTRACT 
 
Background: Post-operative pain is usually nociceptive but surgical trauma also induces central and peripheral 
sensitization and hyperalgesia .Our aim of this study was to compare the post-operative analgesic efficacy & side 
effects of Nalbuphine and Tramadol in orthopaedic surgeries. Methods:  Eighty patients of ASA grade I & II were 
randomly selected with forty patients in each group. All procedures were done under regional or general anaesthesia 
or combination of both techniques. Patients were assessed every 30 mins for pain scores on VAS in post operative 
period. Group N: received inj Nalbuphine HCL 0.15 mg/kg IV 8 hourly. Group T: received inj Tramadol HCL 2 
mg/kg IV 8 hourly. Time of drug administration , patients VAS at drug injection , time to onset of drug effect (VAS 
reduced to< 4) ,VAS score , vital signs, sedation score, complications and requirement of rescue analgesia were 
observed thereafter Results: Onset of drugs effect and the duration of analgesia after first dose were comparable.  
Nalbuphine was proven to be having longer duration than Tramadol after third dose (p<0.005). There was 
statistically significant hemodynamic stability and higher sedation scores in Nalbuphine group (P<0.005). Nausea, 
vomiting and rescue analgesics used were significantly high in tramadol group (P<0.005).  Conclusion:  Nalbuphine 
produces better pain relief and hemodynamic stability in postoperative period in patients undergoing orthopaedic 
surgeries when compared to tramadol which is associated with more nausea,vomiting and rescue analgesic 
requirement. 
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Introduction 
 
 
Postoperatively pain is often inadequately treated 
leading to a number of complications, therefore the 
pain of surgeries must be relieved totally.[1] Effective 
postoperative pain relief provides mental and economic 
benefits and reduces the onset of chronic pain 
syndromes more common with orthopaedic 
procedures.[2]  
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Many comparisons among opioid molecules have been 
there as a reliable pain relieving entiety in moderate to 
severe pain arising after massive musculoskeletal tissue 
handling in orthopaedic procedures.[3-5] Current study 
is one such attempt, using i.v. bolus doses & 
comparing relative efficacy & side effect profile for 
Nalbuphine and Tramadol. 
 
Material and Method 
 
This study was conducted with the permission of 
ethical committee of hospital after written informed 
consent of 80 adult patients of either sex and ASA 
grade I and II. Patients were posted for wide variety of 
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orthopaedic procedure ranging from minor wound 
debridement to large joint replacement surgeries. 
Patients with diabetes, hypertension, bleeding 
disorders, heart diseases, chronic lung disease, anaemia 
and having history of any substance abuse were 
excluded from the study.All patients were examined 
preoperatively and history noted. All the usually taken 
investigations were asked for. Eighty patients were 
randomly allocated in 2 groups, 40 patients in each 
Group. They were named: Group Nalbuphine and 
Group Tramadol. All patients were given information 
about the nature of study & anaesthetic technique. 
They were instructed to the concept of VAS to record 
pain. Premedication used was Tab Lorazepam 1 mg 
orally on previous night and Tab Diazepam 5 mg orally 
in the morning 3 hours prior to surgery. All the 
procedures were done under regional or general 
anaesthesia or any combination of both of these 
techniques. There was no any binding for the choice of 
anaesthetic technique. But chronological charting of 
analgesic administered intra operatively was done with 
total duration of surgery. Assessment of pain was done 
immediately after the completion of procedure. After 
completion of surgery and shifting the patient to post 
anaesthesia care unit, any other form of analgesia was 
also omitted. Patients were half hourly assessed for 
pain scores on VAS. Group Nalbuphine was given inj 
Nalbuphine HCL 0.15 mg/kg IV diluted till 10 ml 
volume in NS 8 hrs apart. Group Tramadol: was given 
inj Tramadol HCL 2 mg/kg IV diluted till 10 ml 
volume in NS 8 hrs apart. Time of drug administration, 
patient’s VAS at drug injection, time to onset of drug 
effect. (VAS reduced to less than 4), VAS scores, pulse 
rate, BP, adverse effect of drugs, sedation score, and 
rescue analgesic requirement were observed thereafter 
and noted. Onset of drug action was defined as VAS 
reaches less than 4 after injection Pain was assessed by 
using VAS initially every 5 min till 30 min, every 30 
min till 2 hrs, hrly till 6 hrs, then at 8 hr, 12 hr and 24 
hr duration. 
Visual analogue scale: 0: No pain 
                              1-4: Mild pain  
                                      5-7: Moderate pain  
                                      8-10:  Severe pain  
As the VAS again reaches 7 or more rescue analgesic 
was administered in the form of injection Diclofenac 
sodium 1.5 mg/kg IV diluted till 10 ml in NS. 
Hemodynamic and respiratory parameters were 
observed post operatively. Pulse , BP , respiratory rate 
,and SpO2 were noted initially every 5 min till 30 min , 
then every 30 mins till 2 hrs , then hrly till 6 hrs and 
then at 8 hr , 12 hr and 24 hr duration. 
Sedation score used was 
              0: alert 
              1: sometimes drowsy/ easily aroused 
               2: often drowsy / easily aroused 
3: often drowsy /difficult to arouse 
4: asleep or stirs to touch 
Patients were monitored continuously for any side 
effect after administration of drug. Duration of drug 
effect was defined as VAS score reaching more than 7 
in observation period after giving the drug. After 
completion of study in 24 hrs, patients were shifted to 
their respective wards after switching them to usual 
post operative analgesic regimen. During data analysis 
all the observations and results were calculated by 
applying students T Test and chi square test using 
SPSS version 17.0. P value less than 0.05 was 
considered statistically significant. 
Results 
The present study includes 80 adult patients of either 
sex : all of them were belonging to ASA grade I and II 
, undergoing variety of orthopaedic surgeries and were 
randomly assigned to two groups of 40 patients each , 
irrespective of surgery and anaesthesia technique. They 
were given post operative analgesics according to 
groups assigned to them; on their 1st complain of pain 
(VAS > 7) after the surgery, repeating the same dose 8 
hrly for 24 hrs in post anaesthesia care unit. 
 Table 1: Demographic data (age, sex and weight distribution) and Type of surgeries 
WE*-Wide Excision 
This table [1] shows that the demographic data and type of surgeries were almost comparable in both the groups.  
 Group Tramadol Group Nalbuphine 
Age in yrs(mean ±SD) 32.60±16.25 35.62±18.22 
Weight. in kgs( mean±SD) 49.90±11.05 53.80±14.69 
Sex (M:F) 20:20 22:18 
Surgery type   
WE*+Reconstructions 16(40%) 13(32.5%) 
WE*or Bone curettage 9(22.5%) 11(27.5%) 
Local debridement/nailing 2(5%) 3(7.5%) 
Limb amputations 5(12.5%) 4(10%) 
Joint replacements / major joint surgery 8(20%) 9(22.5%) 
Total cases  40(100%) 40(100%) 
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Table 2: Onset of drug effect and Duration of action 
 Group Tramadol Group Nalbuphine 
Onset of effect (min)(Mean±SD) 9.37±4.55 7.95±3.94 
Duration of 1st dose(hr) 5±1.55 5.05±1.23 
Duration of 2nd dose(hr) 5.57±0.78 5.90±1.23 
Duration of 3rd dose(hr) 6.22±0.66 7.12±0.93 
Onset of drugs effect was found comparable after 
applying student’s t-test, among both the groups. Two 
tailed probability was found 0.1387 with no significant 
difference. Table 2 explains that after 1st dose the 
duration of analgesia exerted by both the drugs was 
comparable. Later on with successive doses it became 
significant and Nalbuphine was proven to be having 
longer duration than Tramadol after 3rd dose (p-
value<0.005) 
Fig 2: changes in pulse rate in both groups (BPM) 
Changes in pulse rates were found statistically 
significant in patients receiving Nalbuphine with the 
mean  pulse rate within 81.625±1.04 BPM in 
comparison to patients receiving Tramadol with  the 
mean pulse rate within 84.694±1.25 BPM (p value 
<0.005) [figure-2]. None of the patient experienced 
profound bradycardia in both groups. 
Fig 3: Changes in SBP in both groups (mmHg) 
 
Changes in SBP were found statistically significant in 
patients receiving  Nalbuphine with mean SBP  
 
 
 
121.65±0.96 mmHg in comparison to patients 
receiving Tramadol with mean SBP 124.04±1.19 
mmHg (p value <0.005)[figure-3] . None of patients in 
both groups had Hypotension. 
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Fig 4: changes in DBP in both groups (mmHg) 
Changes in DBP were found comparable in both groups [figure-4]. 
 
Table 3: sedation scores and rescue analgesic doses requirements after both the drugs 
 Tramadol Group Nalbuphine Group 
Average Sedation Score(Mean 
±SD) 
0.125±0.335 1.025±0.577 
Average number of Rescue doses 
(Mean±SD) 
3.05±0.639 2.25±0.927 
                 
 
  
Fig 5: Average sedation score and no of rescue analgesia 
Average sedation scores were significantly higher in 
Nalbuphine Group(P<0.0001), but none of the patient 
had a score higher than 2( often drowsy/easily 
aroused).Further rescue  analgesics  used were 
significantly high in Tramadol Group with maximum 4 
doses used in 9 patients and in Nalbuphine Group 
maximum 4 doses were used in 3 
patients(P<0.0001).[table-3] 
 
Table 4: incidences of adverse drug reactions 
 Tramadol 
Group 
Nalbuphine Group 
Nausea/vomiting 62.5% 7.5% 
Resp.Depression Nil 5% 
Hypotension Nil Nil 
Hypertension Nil Nil 
Psycho mimetic 
reaction 
Nil Nil 
others Nil Nil 
Tramadol has significant propensity towards nausea 
and vomiting (<0.0001)while some degree of 
respiratory depression was observed with nalbuphine 
only, but it was of mild degree and SpO2 never fell 
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below 95% in these two patients while respiratory rate 
was reduced to 12/min from the higher baseline 
respiratory rates[Table4]. 
 
Discussion  
 
Under treatment of post operative pain is due to lack of 
knowledge regarding effective dose ranges, duration of 
action of opioids , unfounded fear of respiratory 
depression and addiction in hospitalized patients 
experiencing pain. This study was undertaken to 
compare the analgesic efficacy & safety profile of 
opioid agonist-antagonist Nalbuphine with one of the 
most common agent used in clinical practice for post 
operative pain relief, Tramadol Nalbuphine is a 
semisynthetic opioid of phenanthrene series which is 
related structurally to the agonist Oxymorphone & the 
antagonist Naloxone.[6]  Nalbuphine exhibits an 
analgesic potency & a ceiling effect for respiratory 
depression.[7]Tramadol, a synthetic opioid of the 
aminocyclohexanol group is a centrally acting 
analgesic with weak opioid agonist properties and 
effects on noradrenergic and serotonergic 
neurotransmission. These opioid & nonopioid modes of 
action appear to act synergistically.[8]Tramadol has 
been shown to provide effective analgesia for post 
operative pain. It is generally well tolerated the most 
common adverse events being nausea & vomiting. 
[5]H. Krenna et al. have compared Nalbuphine bolus 
and continuous intravascular administration in post 
operative pain & found that both regimens were 
equally effective & significantly low amount of drug 
was used in bolus group & recommended this schedule 
for cost effectiveness. [10]M.Woolland et al. have 
proved that low dose Nalbuphine results in low adverse 
events but offers poor control for high proportion of 
patients. [11]Our study shows that Nalbuphine has 
mean onset of analgesia 7.95 min with Nalbuphine & 
9.37 min with Tramadol with no significant difference. 
9 patients in Tramadol group & 4 patients in 
Nalbuphine group required maximum 4 doses of rescue 
analgesia with an average of 3.05 & 2.25 doses 
required in Tramadol & Nalbuphine group 
respectively. Hakki Unlugane et al. have reported that 
Tramadol requires more cumulative analgesic 
consumption over 24 hours and more doses of fentanyl 
as a rescue analgesia in comparison with morphine & 
pethidine.[12]Both the drugs have almost same 
duration with the 1st dose and with subsequent doses 
duration of analgesia provided by Nalbuphine 
increased significantly whereas Tramadol provided 
equal duration with subsequent doses & needed 
significantly high use of rescue analgesia.F.N.Minai, 
F.A.Khan have observed that the time between the last 
intraoperative and 1st postoperative dose was 
significantly higher in Nalbuphine group (5.8 hrs) then 
Morphine group (4 hrs).[13]In our study hemodynamic 
parameters were also seem to be better preserved in 
Nalbuphine group in comparison to patients receiving 
tramadol. RA Green et al. reported slight fall in SBP 
with Nalbuphine in coronary artery disease 
patients.[14]Khalid Maudood et al. also reported better 
hemodynamic stability with Nalbuphine compared to 
Tramadol in perioperative settings.[15]None of the 
patients had significant sedation in both the groups 
except 7 patients of Nalbuphine group who had 
sedation score 2/5. But all patients were easily 
arousable. Average sedation score was significantly 
higher in Nalbuphine group (1.025) than Tramadol 
group (0.125).Nausea & vomiting were significantly 
higher in Tramadol group i.e. 62 % compared to 7.5% 
in Nalbuphine group.In Nalbuphine group 2 patients 
had respiratory depression with respiratory rate 
maintained at 12/min & SpO2 was >92% all the time 
of study, with subsequent doses also the condition 
remained the same.Pang ww et al. have reported more 
nausea & vomiting in Tramadol than Morphine (40 % 
vs. 11%) & (28% vs. 5%). [5]In a study done by FN 
Minai et al., less number of patients had nausea & 
vomiting in Nalbuphine group compared to Morphine. 
[13] 
 
Conclusion 
 
Nalbuphine appears to be better analgesic for the relief 
of moderate to severe postoperative pain in orthopaedic 
patients. It provides good sedation, hemodynamic 
stability and lower incidence of nausea & vomiting 
compared to Tramadol. Nalbuphine also exhibits a 
ceiling effect for respiratory depression. 
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